Laurence J. Freedman

Jan 22, 2025 | mondaq.com | Grady Campion |Laurence J. Freedman |Kevin M. McGinty

In 2024, federal courts issued a number of important decisionsin False Claims Act (FCA) cases that are particularly noteworthyfor the health care and life sciences industries. We focus here ondecisions that further develop the FCA scienter standard addressedin 2023 by the Supreme Court in its important SuperValudecision. We also look at decisions that have accepted theinvitation of three Supreme Court justices to reexamine theconstitutionality of the FCA's qui tam provisions.

Nov 21, 2024 | mondaq.com | Laurence J. Freedman |Xavier G. Hardy |Abdie Santiago

On November 12, 2024, the drug manufacturer Johnson & Johnson (J&J) filed a lawsuit against the Health Resources and Services Administration (HRSA) in the United States District Court for the District of Columbia. The lawsuit relates to J&J's proposal to require certain 340B covered entities – specifically, disproportionate share hospitals (DSH) – that purchase J&J's drugs Stelara and Xarelto under the 340B Drug Pricing Program (340B Program) to do so under a rebate model.

Nov 19, 2024 | natlawreview.com | Laurence J. Freedman

On November 12, 2024, the drug manufacturer Johnson & Johnson (J&J) filed a lawsuit against the Health Resources and Services Administration (HRSA) in the United States District Court for the District of Columbia. The lawsuit relates to J&J’s proposal to require certain 340B covered entities – specifically, disproportionate share hospitals (DSH) – that purchase J&J’s drugs Stelara and Xarelto under the 340B Drug Pricing Program (340B Program) to do so under a rebate model.

Aug 27, 2024 | mondaq.com | Laurence J. Freedman |Scott Lashway

Members Scott Lashway, Laurence Freedman, and Special Counsel Matthew Stein published an article in Bloomberg Law about how recent False Claims Act (FCA) settlements show a focus on cybersecurity enforcement. In the article, they outline how organizations with government contracts can mitigate the risk of cybersecurity-related FCA investigations and litigation.

Aug 16, 2024 | today.westlaw.com | Laurence J. Freedman |Rachel Yount

Enter to open, tab to navigate, enter to select